# US 2025/0144360 A1 · Gas washout vent for patient interface

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144360 A1
- Document ID: US20250144360A1
- Status: Published application
- Kind: A1
- Application number: 19/019,191
- Filed: 2025-01-13
- Published: 2025-05-08
- Earliest claimed: 2014-09-18
- Assignees: ResMed Pty Ltd
- Applicants: ResMed Pty Ltd
- Inventors: Muditha Pradeep DANTANARAYANA
- Web page: https://patentgrep.com/patent/US20250144360A1

## CPC

- A61M 16/22: Carbon dioxide-absorbing devices {; Other means for removing carbon dioxide}(cartridges with absorbing substances for respiratory apparatus A62B19/00)
- A61M 16/06: Respiratory or anaesthetic masks
- A61M 16/0622: {having an underlying cushion}
- A61M 16/0666: {Nasal cannulas or tubing (devices for improving normal breathing through the nose A61F5/08; nose filters A62B23/06; outside holding devices A61M25/02)}
- A61M 16/0683: {Holding devices therefor}
- A61M 16/0816: {Joints or connectors}
- A61M 16/0825: {with ball-sockets}
- A61M 16/0616: {with face sealing means comprising a flap or membrane projecting inwards, such that sealing increases with increasing inhalation gas pressure}
- A61M 2202/0225: Carbon oxides, e.g. Carbon dioxide
- A61M 2205/42: Reducing noise
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A gas washout vent, and a patient interface with the gas washout vent, configured to allow patient-exhaled CO2 to flow to an exterior of the plenum chamber to minimise rebreathing of exhaled CO2 by the patient, the gas washout vent including at least one outlet orifice; a diffusing member at least partly covering the outlet orifice; and a blocking member having an air-impermeable material, the blocking member preventing gas exiting from the outlet orifice from flowing straight through the diffusing member.

## Claims

### Claim 1

A patient interface for sealed delivery of a flow of air at a continuously positive pressure with respect to ambient air pressure to an entrance to the patient's airways including at least an entrance of a patient's nares, wherein the patient interface is configured to maintain a therapy pressure in a range of about 4 cmH2O to about 30 cmH2O above ambient air pressure in use, throughout the patient's respiratory cycle, while the patient is sleeping, to ameliorate sleep disordered breathing, the patient interface comprising:
a sealing structure configured to seal around the entrance to the patient's airways;
a positioning and stabilising structure to maintain the sealing structure in sealing contact with an area surrounding the entrance to the patient's airways while maintaining a therapeutic pressure at the entrance to the patient's airways;
a plenum chamber configured to be pressurised at a pressure above ambient pressure in use;
a gas washout vent configured to allow patient-exhaled CO2 to flow to an exterior of the plenum chamber to minimise rebreathing of exhaled CO2 by the patient, the gas washout vent including at least one outlet orifice;
a diffusing member at least partly covering the outlet orifice; and
a blocking member having an air-impermeable material, the blocking member preventing gas exiting from the outlet orifice from flowing straight through the diffusing member.

### Claim 2 (depends on 1)

The patient interface according to claim 1, wherein the diffusing member and the blocking member are configured to direct the gas exiting from the outlet orifice outward from the diffusing member in an orientation different than the outlet orifice.

### Claim 3 (depends on 1)

The patient interface according to claim 1, wherein the diffusing member provides a flow path parallel to a surface of the blocking member that is in contact with the diffusing member.

### Claim 4 (depends on 1)

The patient interface according to claim 1, wherein the diffusing member is a porous material.

### Claim 5 (depends on 1)

The patient interface according to claim 1, wherein the diffusing member is an open cell foam.

### Claim 6 (depends on 1)

The patient interface according to claim 1, wherein the diffusing member is fibrous material.

### Claim 7 (depends on 1)

The patient interface according to claim 1, wherein the blocking member is fixed to the diffusing member along a surface of the blocking member that contacts the diffusing member.

### Claim 8 (depends on 7)

The patient interface according to claim 7, wherein the surface of the blocking member is opposite the outlet orifice with respect to a thickness of the diffusing member.

### Claim 9 (depends on 1)

The patient interface according to claim 1, further comprising a plurality of outlet orifices.

### Claim 10 (depends on 9)

The patient interface according to claim 9, wherein the diffusing member covers each of the plurality of outlet orifices.

### Claim 11 (depends on 1)

The patient interface according to claim 1, wherein an axis defined by a center of the orifice is not perpendicular to a nearest surface of the diffusing member.

### Claim 12 (depends on 1)

The patient interface according to claim 1, wherein the air-impermeable material is a flexible material.

### Claim 13 (depends on 1)

The patient interface according to claim 1, wherein the air-impermeable material is a rigid material.

### Claim 14 (depends on 1)

The patient interface according to claim 1, further comprising a channel configured to allow liquid to drain away from the outlet orifice.

### Claim 15 (depends on 14)

The patient interface according to claim 14, wherein the orifice is in the channel.

### Claim 16 (depends on 15)

The patient interface according to claim 15, wherein the channel has a V-shaped or U-shaped cross-section.

### Claim 17 (depends on 16)

The patient interface according to claim 16, wherein the orifice is in a leg of the V-shaped or U-shaped cross section.

### Claim 18 (depends on 1)

The patient interface according to claim 1, wherein the blocking member comprises holes configured to redirect the gas exiting from the orifice.

### Claim 19 (depends on 18)

The patient interface according to claim 18, wherein the holes include multiple orientations of the holes that are configured to redirect the gas in multiple directions.

### Claim 20 (depends on 1)

The patient interface according to claim 1, wherein the diffusing member and the blocking member are removably attached to the plenum chamber.
